Abstract
Over 400,000 U.S. military personnel have been diagnosed with a mild or moderate traumatic brain injury (TBI) since the year 2000. Posttraumatic headache (PTH) is one of the most common and bothersome sequela after a mild or moderate head injury. Persistent posttraumatic headache are headaches due to the head injury lasting longer than 3 months. About 40% of military personnel who develop PTH after a TBI have persistent PTH and about 20% have PTH lasting longer than a year after the original injury. Persistent PTH has a negative impact on daily activities, including work and social functioning.
There are no available guidelines for treating posttraumatic headache, and there is extraordinary variability in treatment practices as a result. The present study aims to identify predictive factors that account for heterogeneity in response to behavioral intervention for posttraumatic headache attributable to mild to moderate TBI. We intend to create a predictive model of PTH through the adoption of the Predictive Approaches to Treatment effect Heterogeneity Statement (PATH Statement). This rigorous, guided approach will be used to develop and validate a predictive model of psychosocial factors related to PTH treatment outcomes, thereby improving individualized treatment of PTH. This protocol provides an overview of the research design and methods for this study.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study is funded by the Defense Health Agency (W81XWH2120044).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Texas Health Science Center at San Antonio Institutional Review Board. The approval is waived due to the study will involve de-identified data from a local data repository.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Abbreviations Used
- AUDIT
- Alcohol Use Disorders Identification Test
- CBT
- Cognitive-Behavioral Therapy
- CEQ
- Credibility Expectancy Questionnaire
- CSQ-8
- Client Satisfaction Questionnaire 8-item
- DSI-SS
- Depressive Symptom Index – Suicidality Scale
- GAD-7
- Generalized Anxiety Disorder 7-items
- HIT-6
- Headache Impact Test 6-items
- HMSE
- Headache Management Self-Efficacy Scale
- IRB
- Institutional Review Board
- ISI
- Insomnia Severity Index
- LASSO
- Least Absolute Shrinkage and Selection Operator
- PATH
- Predictive Approaches to Treatment effect Heterogeneity
- PCL-5
- PTSD Checklist based on DSM-5 criteria
- PHQ-9
- Patient Health Questionnaire 9-items
- PTSD
- Posttraumatic Stress Disorder
- RCT
- Randomized Controlled Trial
- RSES
- Response to Stressful Experiences Scale
- STOP
- Sleep measure – Snoring, Tiredness, Observed stop breathing, high blood Pressure
- TAU
- Treatment as Usual
- TBI
- Traumatic Brain Injury
- TIF
- Tinnitus Functional Index Questionnaire
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.